Mason A. Chilmonczyk
About Mason A. Chilmonczyk
Mason A. Chilmonczyk CEO and Co-Founder
Mason A. Chilmonczyk is the CEO and Co-Founder known for his significant contributions to the field of diagnostics technology. His work primarily revolves around the development and commercialization of innovative technologies. Through his leadership, the company pursues advanced research and development initiatives.
Development of DynaCHIP Technology
Mason A. Chilmonczyk developed the DynaCHIP technology for his PhD dissertation while studying at the Georgia Institute of Technology under the supervision of Andrei G. Fedorov. The DynaCHIP technology represents a major advancement in diagnostics, leveraging dynamic chip capabilities to enhance medical testing and research outcomes.
Funding and Leadership for DynaCHIP Project
During his postdoctoral tenure, Mason A. Chilmonczyk served as the entrepreneurial and technical lead for the DynaCHIP project. He successfully secured funding from Biolocity and the Georgia Research Alliance, ensuring the project's continuation and supporting its goal to revolutionize diagnostic technologies.
Hands-On Engineering and Design Experience
Mason A. Chilmonczyk's hands-on experience includes a diverse range of roles. He worked at a sheet metal/frame shop and as a design engineer for a pharmaceutical packaging company. These roles provided him with practical engineering skills and design expertise, which he later applied to his projects and ventures in diagnostics technology.
Consulting Expertise in AI Cancer Diagnosis and Resonance-Based Diagnostics Sensors
Mason A. Chilmonczyk has served as a consultant on various projects, including artificial intelligence cancer diagnosis and resonance-based diagnostics sensors. His consulting work allows him to apply his extensive knowledge and technical skills to advance these specialized areas of medical diagnostics.
PhD from Georgia Institute of Technology
Mason A. Chilmonczyk holds a PhD from the Georgia Institute of Technology. His academic background and rigorous education have underpinned his research and development efforts, contributing to his role as a leader in diagnostics technology innovation.